ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

REGN34 Regeneron Pharmaceuticals Inc

93.15
1.60 (1.75%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Regeneron Pharmaceuticals Financial Summary

The current REGN34 market cap is 9.98B. The company's latest EPS is USD 36.9050 and P/E is 28.09.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 3.16B3.16B3.36B3.43B3.15B
Operating Income 946.7M1.02B1.11B972.9M751.4M
Net Income 817.8M968.4M1.01B1.16B722M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 7.86B8.78B16.12B12.26B13.12B
Operating Income 2.21B3.58B8.95B4.74B4.05B
Net Income 2.12B3.51B8.08B4.34B3.95B
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 30.06B30.66B32.16B33.08B34.37B
Total Liabilities 6.56B6.64B7.26B7.11B7.38B
Total Equity 23.5B24.02B24.9B25.97B26.99B
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 14.81B17.16B25.43B29.21B33.08B
Total Liabilities 3.72B6.14B6.67B6.55B7.11B
Total Equity 11.09B11.03B18.77B22.66B25.97B
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 1.37B2.39B3.5B4.59B1.51B
Investing -235.7M-2.62B-3.12B-3.19B-1.69B
Financing -322.5M-936.7M-1.34B-1.79B47.1M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 2.43B2.62B7.08B5.01B4.59B
Investing -2.03B-70.6M-5.38B-3.78B-3.19B
Financing -252.1M-1.97B-1.01B-1.01B-1.79B
Market Cap 9.98B
Price to Earnings Ratio 28.09
Price to Sales Ratio 8.46
Price to Cash Ratio 40.67
Price to Book Ratio 4.28
Dividend Yield -

Share Statistics

Shares Outstanding 107.13M
Average Volume (1 week) 1.51k
Average Volume (1 Month) 921
52 Week Change 50.44%
52 Week High 93.17
52 Week Low 55.99
Spread (Intraday) 29.17 (31.31%)

Company Info

Company Name Regeneron Pharmaceuticals Inc
Address 28 liberty street
new york, new york 10005
Website https://www.regeneron.com
Industry health care diversified (H)

Your Recent History

Delayed Upgrade Clock